How Do BRCA1 and BRCA2 Mutations Cause Breast Cancer?
A mutation in the BRCA gene, specifically BRCA1 or BRCA2, significantly increases a woman’s lifetime risk of developing breast cancer. Read this blog to know more.
Why is Triple Negative Breast Cancer hard to detect & treat?
October is Breast Cancer Awareness Month, and Karkinos Healthcare is investing significant efforts to raise awareness of specific types of breast cancer. This article will delve into the risk factors, symptoms, genetic screening, and treatment modalities of Triple-Negative Breast Cancer.
Next gen diagnostics – On the horizon of new efficiencies in cancer care
The practice of Next Generation Sequencing (NGS) is the new buzz word in oncology practice. Regarded as the next horizon in cancer diagnostics, Next-Generation Sequencing (NGS) is gaining importance as it allows for a comprehensive analysis of an individual’s tumor DNA, providing insights into the specific genetic changes driving the tumor and informing treatment options.